The impact of COVID-19 shielding on the wellbeing, mental health and treatment adherence of adults with cystic fibrosis-Reference-Cited by-同舟云学术

The impact of COVID-19 shielding on the wellbeing, mental health and treatment adherence of adults with cystic fibrosis

Published:2021-01-06 Issue:1 Volume:8 Page:e47-e49
ISSN:2514-6645
Container-title:Future Healthcare Journal
language:en
Short-container-title:Future Healthc J

Author:

Westcott Kristina A,Wilkins Frances,Chancellor Amelia,Anderson Alan,Doe Simon,Echevarria Carlos,Bourke Stephen J

Publisher

Royal College of Physicians

Reference14 articles.

1. UK Government . Guidance on shielding and protecting people who are clinically extremely vulnerable from COVID-19. www.gov.uk/government/publications/guidance-on-shielding-and-protecting-extremely-vulnerable-persons-from-covid-19/guidance-on-shielding-and-protecting-extremely-vulnerable-persons-from-covid-19 [Accessed 13 April 2020].

2. National Institute for Health and Care Excellence . COVID-19 rapid guideline: cystic fibrosis. NICE guideline [NG170]. NICE, 2020. www.nice.org.uk/guidance/ng170.

3. National Institute for Health and Care Excellence . CFHealthHub for managing cystic fibrosis during the COVID-19 pandemic. Medtech innovation briefing [MIB219]. NICE, 2020. www.nice.org.uk/guidance/mib219.

4. A Brief Measure for Assessing Generalized Anxiety Disorder

5. The PHQ-9

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The cost of implementing the COVID-19 shielding policy in Wales;BMC Public Health;2023-11-26

2. Longitudinal mental health trends in cystic fibrosis;Journal of Cystic Fibrosis;2023-11

3. Mental health and life satisfaction among those advised to shield during the COVID-19 pandemic in the UK: a secondary analysis of the Understanding Society longitudinal study;Frontiers in Public Health;2023-09-27

4. Innovate and Stockpile: Respiratory Protection for Essential Workers in a Catastrophic Pandemic;Health Security;2023-08-01

5. Suicide attempts in adolescents with cystic fibrosis on Elexacaftor/Tezacaftor/Ivacaftor therapy;Journal of Cystic Fibrosis;2023-05